Cherry-Flavoured Malaria Drug Launched For Children In Africa - UK's Department For International Development Funds Innovative Anti-Malaria Research
Main Category: Tropical DiseasesAlso Included In: Pediatrics / Children's Health; Compliance
Article Date: 23 Mar 2009 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A new child-friendly malaria drug which will be distributed in Africa, where a child dies every 30 seconds from malaria, is to be launched in the UK on Monday 23 March 2009.
The new drug is the result of public-private collaboration between Medicines for Malaria Venture (MMV), a non-profit funded by the UK's Department for International Development, and the drug company Novartis. At the All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases launch on Monday, UK International Development Minister Ivan Lewis will announce an additional £19 million of funding from 2010 for MMV to continue their ground-breaking research against malaria.
Children were prone to spit out the bitter malaria drug for adults, but the new paediatric version, called Coartem D, is cherry-flavoured and dissolves easily in water or breast milk. On average the entire course will cost approximately 30 cents. There are at least 50 million cases of malaria worldwide each year and at least 1 million deaths, mainly among children.
International Development Minister Ivan Lewis said:
"This is an excellent example of how aid can transform peoples' lives. As a result of the contribution of British taxpayers, the lives of millions of children will be saved. This investment in a quicker, cheaper and better-tasting malaria drug will pay off enormously and we are pleased to support this innovative venture."
In the MMV video clip below, Angelina, a single mother of four living in Western Kenya, tells the story of her two-year-old daughter's scrape with death when she contracted malaria and the positive results brought by Coartem-D. View Video
Source
UK's Department for International Development
Visit our tropical diseases section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/143286.php>
APA
http://www.medicalnewstoday.com/releases/143286.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



